Lifestyle changes key to diabetes prevention
EU-funded researchers and clinicians have gone head to head with diabetes and it looks as though they are winning the fight (Pubmed Diabetes)
Launch of Europe-wide recommendations for preventing type 2 diabetes
Researchers and clinicians from across the UK have been part of a pan-European team that has developed the first Europe wide strategy for the prevention of type 2 diabetes (Genetic Engineering & Biotechnology News)
Parents’ fear of hypoglycaemia impacts on children’s diabetes management
Parents who live in fear of their children having hypoglycaemic episodes might have a negative effect on their child’s diabetes control, says a new study (Diabetes UK)
Thirty-One Novel Biomarkers as Predictors for Clinically Incident Diabetes
We identified novel biomarkers that were associated with the risk of clinically incident diabetes over and above the classic risk factors. This gives new insights into the pathogenesis of diabetes and may help with targeting prevention and treatment (PLoS)
Estimated average glucose and self-monitored mean blood glucose are discordant estimates of glycemic control
eAG underestimated MBG in low HGI patients and overestimated MBG in high HGI patients. Disagreement between eAG and MBG downloaded from patient glucose meters will cause confusion if eAG is implemented for clinical use (Diabetes Care)
Hypoglycemia, death associated with false GDH-PQQ test strip readings
Falsely elevated glucose levels — a result of interfering sugars on glucose dehydrogenase pyrroloquinoline quinone-based test strips — may pose a safety risk for patients, according to a recent review (Endocrine Today)
Two hormones are better than one?
An artificial pancreas or closed loop system that can automatically regulate blood sugar levels by not only giving insulin according to the body’s minute to minute needs, but also administering glucagon automatically as well (JDRF)
Barriers to Follow-up for Women with a History of Gestational Diabetes
We surveyed primary care providers (PCPs) and obstetric and gynecology care providers (OBCPs) in a large health system (American Journal of Perinatology)
No Effect of the 1a,25-dihydroxyvitamin D3 on Beta Cell Residual Function and Insulin Requirement in Adults with New-Onset Type 1 Diabetes
Treatment with 1,25(OH)2D3 at a daily dose of 0.25 µg was safe, but did not reduce loss of beta cell function (Diabetes Care)
Insulin Resistance is Associated with Microangiopathy in Type 1 Diabetic Patients
The results show that in patients with DM1, treated from the initial diagnosis with intensive insulin therapy, there is an independent relationship between IR and the diabetic microangiopath (Experimental & Clinical Endocrinology & Diabetes)
Roche expands its position in the growing insulin delivery systems market
Roche and Elron Electronics Ltd have announced that they have signed an agreement under which Roche will acquire 100% of Medingo Ltd, a majority-owned subsidiary of the Elron group (Pharmacy Europe)
CureDM Partners Novel Diabetes Treatment with Sanofi-Aventis
CureDM, LLC announced today that an agreement has been signed with Sanofi-Aventis for the exclusive worldwide license of Pancreate™, a novel islet neogenesis agent for the treatment of type 1 and type 2 diabetes (PharmaLive)
Positive results for diabetes drug
A diabetes drug developed by Sanofi-Aventis could significantly improve blood sugar level control, a Phase III study has found (Pharmacy Europe)
Glycosmedia is also available as an App: